Revvity (MEX:PKI) Short-Term Debt: MXN10,384 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

MEX:PKI Revvity Inc MEX:PKI
60 GF Score
Price MXN1,900.00
GF Value MXN2,151.87
Valuation Modestly Undervalued
! 9 Warning Signs
View Full Analysis

What is Revvity Short-Term Debt?

Revvity MEX:PKI +15.51% 60 Short-Term Debt is MXN10,384 Mil as of Mar. 2026. GuruFocus rates MEX:PKI with a GF Score™ of 60/100 and a GF Value™ of MXN2,151.87 (Modestly Undervalued). The stock has 9 warning signs investors should review.

Revvity's Short-Term Debt for the quarter that ended in Mar. 2026 was MXN10,384 Mil.

Revvity's quarterly Short-Term Debt declined from Sep. 2025 (MXN10,710 Mil) to Dec. 2025 (MXN10,602 Mil) and declined from Dec. 2025 (MXN10,602 Mil) to Mar. 2026 (MXN10,384 Mil).

Revvity's annual Short-Term Debt declined from Dec. 2023 (MXN12,253 Mil) to Dec. 2024 (MXN5 Mil) but then increased from Dec. 2024 (MXN5 Mil) to Dec. 2025 (MXN10,602 Mil).

Revvity Short-Term Debt Explanation

Short-Term Debt represents the total amount of Long-Term Debt such as bank loans and commercial paper, which is due within one year.

Revvity Short-Term Debt Related Terms

Revvity Short-Term Debt Historical Data

* Premium members only.

The historical data trend for Revvity's Short-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Revvity Short-Term Debt Chart

Revvity Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Short-Term Debt
Get a 7-Day Free Trial Premium Member Only Premium Member Only 86.98 9,181.23 12,253.23 5.05 10,602.26

Revvity Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Short-Term Debt Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 4.95 4.33 10,710.15 10,602.26 10,383.79
MEX:PKI
60GF Score
Revvity Inc MEX:PKI
Short-Term Debt is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
Frequently Asked Questions Learn more about Short-Term Debt →
What does a Short-Term Debt of MXN10,384 Mil mean?
Revvity (MEX:PKI) has a Short-Term Debt of MXN10,384 Mil as of Mar. 2026.
Is Revvity's Short-Term Debt too high?
Revvity's current Short-Term Debt is MXN10,384 Mil. Overall, Revvity has a GF Score™ of 60/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Revvity's Short-Term Debt compare to ICLR and CRL?
Revvity's Short-Term Debt of MXN10,384 Mil can be compared against companies in the Medical Diagnostics & Research industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Short-Term Debt for a Medical Diagnostics & Research company?
A good Short-Term Debt depends on the Medical Diagnostics & Research industry context. However, Short-Term Debt should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Short-Term Debt mean?
A high Short-Term Debt can signal that a stock is expensive relative to its fundamentals. Revvity's current Short-Term Debt is MXN10,384 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Revvity stock overvalued right now?
Based on GuruFocus' analysis, Revvity (MEX:PKI) is currently considered Modestly Undervalued. The stock's GF Value™ is MXN2,151.87, compared to a current price of MXN1,900.00 — trading 11.7% below its estimated fair value. The current Short-Term Debt is MXN10,384 Mil. Revvity's overall GF Score™ is 60/100 with 9 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Short-Term Debt calculated?
Short-Term Debt is calculated from a company's financial statements. For Revvity (MEX:PKI), the current Short-Term Debt is MXN10,384 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Revvity (MEX:PKI) Overvalued in 2026?

Based on GuruFocus' analysis, Revvity stock appears to be undervalued. The current stock price of MXN1,900.00 is trading 11.7% below its estimated GF Value™ of MXN2,151.87. GuruFocus considers Revvity to be Modestly Undervalued.

Key valuation signals for MEX:PKI:

  • Short-Term Debt: MXN10,384 Mil
  • GF Value™: MXN2,151.87 vs. price of MXN1,900.00 (11.7% below fair value)
  • GF Score™: 60/100 with 9 warning signs

No single metric tells the full story. See the MEX:PKI stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Revvity Business Description

Address 77 4th Avenue, Waltham, MA, USA, 02451
Revvity is a global life sciences and diagnostics company formed in 2023 following the rebranding of PerkinElmer. The company operates in two segments: life sciences, which provides reagents and instruments for biopharma and academic research, and signals software, and diagnostics, which offers tools in immunodiagnostics and newborn and reproductive health. Revvity's products and services are sold worldwide, with major markets in the US, Europe, and China.
60GF Score

Get the complete analysis for MEX:PKI

Short-Term Debt is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

MXN1,900.00
Price
MXN2,151.87
GF Value